Nucleic Acid Delivery to the Vascular Endothelium
- PMID: 36251765
- PMCID: PMC10673694
- DOI: 10.1021/acs.molpharmaceut.2c00653
Nucleic Acid Delivery to the Vascular Endothelium
Abstract
This Review examines the state-of-the-art in the delivery of nucleic acid therapies that are directed to the vascular endothelium. First, we review the most important homeostatic functions and properties of the vascular endothelium and summarize the nucleic acid tools that are currently available for gene therapy and nucleic acid delivery. Second, we consider the opportunities available with the endothelium as a therapeutic target and the experimental models that exist to evaluate the potential of those opportunities. Finally, we review the progress to date from investigations that are directly targeting the vascular endothelium: for vascular disease, for peri-transplant therapy, for angiogenic therapies, for pulmonary endothelial disease, and for the blood-brain barrier, ending with a summary of the future outlook in this field.
Keywords: endothelium; nanoparticle; nonviral vehicle; nucleic acid delivery; polymeric vehicle; polyplex.
Figures
References
-
- Aird WC, Spatial and temporal dynamics of the endothelium. J Thromb Haemost 2005, 3, 1392–1406. - PubMed
-
- Pugsley MK; Tabrizchi R, The vascular system: An overview of structure and function. J Pharmacol Tox Met 2000, 44, 333–340. - PubMed
-
- Aird WC, Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 2007, 100 (2), 158–73. - PubMed
-
- Potente M; Makinen T, Vascular heterogeneity and specialization in development and disease. Nat Rev Mol Cell Biol 2017, 18 (8), 477–494. - PubMed
-
- Pober JS; Sessa WC, Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 2007, 7 (10), 803–15. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources